Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review

BACKGROUND: There is currently at least 1 biologic (adalimumab) approved in North America for treatment of Hidradenitis Suppurativa in the pediatric population. However, no reviews or clinical trials have specifically analyzed the effectiveness and safety data of biologic use in this population. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachdeva, Muskaan, Kim, Patrick, Mufti, Asfandyar, Maliyar, Khalad, Sibbald, Cathryn, Alavi, Afsaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978460/
https://www.ncbi.nlm.nih.gov/pubmed/34587768
http://dx.doi.org/10.1177/12034754211049711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978460/
https://www.ncbi.nlm.nih.gov/pubmed/34587768
http://dx.doi.org/10.1177/12034754211049711

Ejemplares similares